Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : ALNY    crawled date : 2021 - 03 - 23    save search
Alnylam to Present Full 9-Month Results from the HELIOS-A Phase 3 Study of Vutrisiran at the American Academy of Neurology Virtual Annual Meeting 2021
Published: 2021-03-23 (Crawled : 14:00) - biospace.com/
ALNY | $144.315 -0.58% -0.59% 700K twitter stocktwits trandingview |
Health Technology
 | | O: -0.53% H: 0.18% C: -3.29%
results phase 3
Gainers vs Losers
67% 33%

Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.